Literature DB >> 22361391

Role of passive immunotherapies in managing infectious outbreaks.

A O Ian Gust1.   

Abstract

The historical and current role of passive immunization in managing outbreaks of infectious diseases reviewed.
Copyright © 2012 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22361391     DOI： 10.1016/j.biologicals.2012.01.001

Source DB:  PubMed          Journal:  Biologicals        ISSN： 1045-1056            Impact factor:   1.856


  5 in total

Review 1.  Antibody immunoprophylaxis and immunotherapy for influenza virus infection: Utilization of monoclonal or polyclonal antibodies?

Authors:  Cassandra M Berry
Journal:  Hum Vaccin Immunother       Date:  2017-11-07       Impact factor: 3.452

2.  Preserved antiviral adaptive immunity following polyclonal antibody immunotherapy for severe murine influenza infection.

Authors:  Natalie E Stevens; Antoinette Hatjopolous; Cara K Fraser; Mohammed Alsharifi; Kerrilyn R Diener; John D Hayball
Journal:  Sci Rep       Date:  2016-07-06       Impact factor: 4.379

3.  Therapeutic antibodies for infectious diseases.

Authors:  Erin Sparrow; Martin Friede; Mohamud Sheikh; Siranda Torvaldsen
Journal:  Bull World Health Organ       Date:  2017-02-02       Impact factor: 9.408

4.  Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG.

Authors:  Oleg V Pyankov; Yin Xiang Setoh; Sergey A Bodnev; Judith H Edmonds; Olga G Pyankova; Stepan A Pyankov; Gabor Pali; Shane Belford; Louis Lu; Mylinh La; George Lovrecz; Valentina A Volchkova; Keith J Chappell; Daniel Watterson; Glenn Marsh; Paul R Young; Alexander A Agafonov; Jillann F Farmer; Victor E Volchkov; Andreas Suhrbier; Alexander A Khromykh
Journal:  Sci Rep       Date:  2017-02-03       Impact factor: 4.379

Review 5.  Polyclonal hyper immunoglobulin: A proven treatment and prophylaxis platform for passive immunization to address existing and emerging diseases.

Authors:  Tharmala Tharmalingam; Xiaobing Han; Ashley Wozniak; Laura Saward
Journal:  Hum Vaccin Immunother       Date:  2021-05-19       Impact factor: 4.526
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.